CIK: 0001534261 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 13, 2019
Total Value ($000): $1,068,381,974 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SPARK THERAPEUTICS INC | 884,800 | $90,585,824 | 8.5% | $60.22 | — | COM | 84652J103 |
| — | INVITAE CORP | 3,838,388 | $90,202,118 | 8.4% | $10040.39 | — | COM | 46185L103 |
| — | BLUEPRINT MEDICINES CORP | 940,000 | $88,670,200 | 8.3% | $9221.69 | — | COM | 09627Y109 |
| CDXS | CODEXIS INC | 5,073,780 | $86,519,885 | 8.1% | $13.94 | +38.3% | COM | 192005106 |
| — | SAGE THERAPEUTICS INC | 400,000 | $73,236,000 | 6.9% | $89.71 | — | COM | 78667J108 |
| — | MYOKARDIA INC | 1,285,000 | $64,429,900 | 6.0% | $39.07 | — | COM | 62857M105 |
| FATE | FATE THERAPEUTICS INC | 2,550,000 | $51,765,000 | 4.8% | $4.33 | +316.3% | COM | 31189P102 |
| SRPT | SAREPTA THERAPEUTICS INC | 335,000 | $50,903,250 | 4.8% | $127.76 | -4.9% | COM | 803607100 |
| — | BLUEBIRD BIO INC | 372,500 | $47,382,000 | 4.4% | $5243.63 | — | COM | 09609G100 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 650,000 | $47,164,000 | 4.4% | $81.37 | -5.7% | COM | 02043Q107 |
| — | MAGENTA THERAPEUTICS INC | 3,003,121 | $44,296,035 | 4.1% | $1777.95 | — | COM | 55910K108 |
| BLFS | BIOLIFE SOLUTIONS INC | 2,428,571 | $39,408,375 | 3.7% | $15.38 | +13.3% | COM | 09062W204 |
| — | AUDENTES THERAPEUTICS INC | 965,000 | $36,534,900 | 3.4% | $26.14 | — | COM | 05070R104 |
| VYGR | VOYAGER THERAPEUTICS INC | 1,128,075 | $30,706,202 | 2.9% | $14.86 | — | COM | 92915B106 |
| AGIO | AGIOS PHARMACEUTICALS INC | 495,000 | $24,690,600 | 2.3% | $62.09 | -13.9% | COM | 00847X104 |
| ILMN | ILLUMINA INC | 60,000 | $22,089,000 | 2.1% | $196.93 | +60.3% | COM | 452327109 |
| — | GENMARK DIAGNOSTICS INC | 3,365,000 | $21,838,850 | 2.0% | $6.69 | — | COM | 372309104 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | 463,125 | $20,100,347 | 1.9% | $44.30 | 0.0% | COM | 00650F109 |
| — | GRITSTONE ONCOLOGY INC | 1,770,000 | $19,717,800 | 1.8% | $4096.07 | — | COM | 39868T105 |
| — | CONSTELLATION PHARMCETICLS I | 1,523,960 | $18,714,229 | 1.8% | $6.31 | — | COM | 210373106 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,530,000 | $16,478,100 | 1.5% | $8.80 | +20.9% | COM | 800677106 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 300,000 | $15,780,000 | 1.5% | $32.45 | — | COM | 37890U108 |
| — | HOMOLOGY MEDICINES INC | 745,000 | $14,579,650 | 1.4% | $10386.26 | — | COM | 438083107 |
| EDIT | EDITAS MEDICINE INC | 480,000 | $11,875,200 | 1.1% | $29.14 | -18.1% | COM | 28106W103 |
| ALEC | ALECTOR INC | 551,039 | $10,189,059 | 1.0% | $19.47 | +4.3% | COM | 014442107 |
| TWST | TWIST BIOSCIENCE CORP | 300,000 | $8,703,000 | 0.8% | $26.45 | 0.0% | COM | 90184D100 |
| DNLI | DENALI THERAPEUTICS INC | 400,000 | $8,304,000 | 0.8% | $21.34 | +5.0% | COM | 24823R105 |
| CDNA | CAREDX INC | 200,000 | $7,198,000 | 0.7% | $11.47 | +179.1% | COM | 14167L103 |
| STOK | STOKE THERAPEUTICS INC | 85,000 | $2,479,450 | 0.2% | $26.85 | 0.0% | COM | 86150R107 |
| — | TURNING POINT THERAPEUTICS I | 60,000 | $2,442,000 | 0.2% | $40700.00 | — | COM | 90041T108 |
| — | ORCHARD THERAPEUTICS PLC | 100,000 | $1,399,000 | 0.1% | $13990.00 | — | ADR | 68570P101 |